FibroBiologics, Inc. (FBLG) - Latest Market Data

Price & Market Data

Price: $1.03

Daily Change: -$0.02 / 1.94%

Daily Range: $1.00 - $1.09

Market Cap: $5,469,360

Daily Volume: 65,910

Performance Metrics

1 Week: -3.11%

1 Month: -29.59%

3 Months: -78.88%

6 Months: -83.82%

1 Year: -94.22%

YTD: -77.92%

About FibroBiologics, Inc. (FBLG)

In-depth market report for FibroBiologics, Inc. (FBLG). The stock is valued at 1.03, with a daily change of -$0.02 / 1.94%. Market cap: 5,469,360. All key performance metrics are updated, including YTD and 52-week returns.

Company Details

Employees: 15

Sector: Health technology

Industry: Biotechnology

Country: United States

Details

FibroBiologics, Inc., a clinical-stage biotechnology company, engages in the development and commercialization of fibroblast-based therapies for patients suffering from chronic diseases. The company's product pipeline includes CYWC628 which has completed pre-clinical trial for the treatment of wound healing; CYMS101 which has completed Phase 1 trial for the treatment of multiple sclerosis; CybroCell for the treatment of degenerative disc disease; and CYPS317 for the treatment of psoriasis. It also develops early-stage research products, including CYTER915 to treat the human longevity; and TCB190 for the treatment of certain cancers. FibroBiologics, Inc. was incorporated in 2021 and is headquartered in Houston, Texas.

Selected stocks

MEDIROM Healthcare Technologies Inc. (MRM)

Lianhe Sowell International Group Ltd (LHSW)

Aptevo Therapeutics Inc. (APVO)

New Horizon Aircraft Ltd. (HOVR)

Embecta Corp. (EMBC)